Section Arrow
Quote
PRGO.NYSE
- Perrigo Company PLC
Quotes are at least 15-min delayed:2024/11/10 19:16 EST
Last
 26.36
-0.57 (-2.12%)
Day High 
26.9146 
Prev. Close
26.93 
1-M High
27.72 
Volume 
1.63M 
Bid
26.06
Ask
26.36
Day Low
26.2 
Open
26.86 
1-M Low
23.8943 
Market Cap 
3.67B 
Currency USD 
P/E 2,758 
%Yield 4.18 
10-SMA 25.94 
20-SMA 25.45 
50-SMA 26.18 
52-W High 34.6 
52-W Low 23.8943 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-0.91/2.91
Enterprise Value
7.31B
Balance Sheet
Book Value Per Share
33.32
Cash Flow
Cash Flow Yield
0.09
Income Statement
Total Revenue
4.66B
Operating Revenue Per Share
34.12
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands1.49-0.06-3.87%-- 
ESPREsperion Therapeutics2.275+0.165+7.82%-- 
VTRSViatris12.96-0.22-1.67%227.2PE
HLNHaleon plc9.61+0.01+0.10%31.1PE
CGCCanopy Growth Corp4.24-0.31-6.81%-- 
Quotes are at least 15-min delayed：2024/11/10 19:16 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.